Eurofarma, a Brazilian-based multinational pharmaceutical company, has launched an app called Scrolling Therapy, which uses facial recognition to help patients with Parkinson’s disease navigate hypomimia, a loss or reduction of facial expressions that can hinder communication.

Developed by Dentsu Creative and supported by the Brazil Parkinson Association, the app encourages users to practice making facial expressions for 45 minutes a day, controlling social media engagement through facial cues. Scrolling Therapy uses AI-powered facial recognition to let participants scroll up or down, swipe or play videos through different facial expressions, such as smiling, surprise, or sadness. The app is integrated with Facebook and Instagram and complements the treatments already carried out by patients. The tool is intended to generate stimuli on the face, exercise the muscles, and make it easier for patients to work the exercise into their daily lives.

Article written by Sara Century